Facebook
Twitter
LinkedIn
Forward
2nd Annual Conference on Precision Psychiatry: Innovation to Implementation
The Annual Conference on Precision Psychiatry, hosted by the MGH Center for Precision Psychiatry, is becoming a leading venue for showcasing advances in the application of precision medicine approaches to psychiatric research and clinical practice. Our Keynote Speakers will be Dr. Kelsey Martin, Director of the Simons Foundation Autism Research Initiative (SFARI), and Dr. Thomas Insel, former Director of NIMH and author of Healing: Our Path from Mental Illness to Mental Health (Penguin Press, 2022). The Conference will be held virtually over the course of two days: Wednesday, November 2nd and Thursday, November 3rd, 2022. The Conference is designed to cover a broad range of domains including:
- Applications of AI & machine learning in psychiatry
- Genomics and other omics
- Precision therapeutics
- Risk stratification for suicide and other important outcomes
- mHealth and digital technologies
- Implementation science
- Ethics and equity
Pricing
Registration: $200
Students and Trainees: FREE
BEFORE YOU REGISTER: Important Notice
You must create an account through the MGH Psychiatry Academy to register for this event. MGH Psychiatry Academy accounts are not limited to MGH employees. We welcome attendees from around the world and from any organization.
 |
| 1:00pm-1:10pm | Welcome Remarks Jordan W. Smoller, MD, ScD & Maurizio Fava, MD | |
| 1:10pm-1:40pm | Conference Keynote Thomas Insel, MD Former Director of NIMH; Author of Healing: Our Path from Mental Illness to Mental Health (Penguin Press, 2022) | |
| 1:40pm-2:00pm | Moderated Discussion/Q&A Thomas Insel, MD Moderator: Jordan W. Smoller, MD, ScD | |
2:00pm-3:30pm | Session: Leveraging Healthcare Data for Precision Medicine Session Chair: Colin Walsh | |
| 2:00pm-2:30pm | Lea Davis, PhD Associate Professor of Medicine, Biomedical Informatic, Molecular Physiology & Biophysics, and Psychiatry & Behavioral Sciences, Vanderbilt University Medical Center | |
| 2:30pm-3:00pm | Nigam Shah, PhD Professor of Medicine, Stanford University; Associate Dean and Professor of Medicine and Biomedical Data Science, Stanford University School of Medicine | |
| 3:00pm-3:30pm | Moderated Discussion/Q&A Lea Davis, PhD, Nigam Shah, PhD Moderator: Colin Walsh, MD, MA, FAMIA | |
| 3:30pm-3:50pm | BREAK | |
3:50pm-4:20pm | Session: Therapeutics: The Role of Academia and Industry in Advancing Precision Psychiatry Session Chair: Jerrold Rosenbaum, MD | |
| 3:50pm-4:20pm | Panel Jenny Barnett, PhD Chief Executive Officer, Monument Therapeutics; Chief Scientific Officer, Five Lives; Honorary Research Fellow in Dept. of Psychiatry, University of Cambridge; David Olson, PhD Chief Innovation Officer and Head of the Scientific Advisory Board, Delix Therapeutics; Associate Professor, University of California Davis; Morgan Sheng, PhD Core Institute Member and Co-Director of Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard Moderator: Jerrold Rosenbaum, MD | |
4:20pm-5:20pm | Session: Precision Treatment Stratification and Pharmacogenetics Session Chair: Roy Perlis, MD, MSc | |
| 4:20pm-4:50pm | Chad Bousman, PhD CEO/Founder, Sequence2Script Inc.; Associate Professor, University of Calgary | |
| 4:50pm-5:20pm | Katherine Scangos, MD, PhD Medical Director of Neumora | |
| 5:20pm-5:30pm | Closing Remarks Jordan W. Smoller, MD, ScD | |
 |
| 9:00am-9:10am | Welcome Remarks Jordan W. Smoller, MD, ScD | |
| 9:10am-9:40am | Conference Keynote: Kelsey Martin, MD, PhD Director of the Simons Foundation Autism Research Initiative (SFARI), Professor of Biological Chemistry Psychiatry and Biobehavioral Sciences, UCLA | |
| 9:40am-10:00am | Moderated Discussion/Q&A Kelsey Martin, MD, PhD Moderator: Michael Talkowski, PhD | |
10:00am-11:00am | Session: Methods and Tools Session Chair: Karmel Choi, PhD | |
| 10:00am-10:30am | Anthony Philippakis, MD, PhD Chief Data Officer, Broad Institute of MIT and Harvard; Venture Partner, GV | |
| 10:30am-11:00am | Laura Germine, PhD Director of Brain and Cognitive Health Technology, McLean Hospital; Co-director of the Institute for Technology in Psychiatry, McLean Hospital; Assistant Professor, Harvard Medical School; President and Director, The Many Brains Project | |
| 11:00am-12:00pm | Session: Precision Neuroscience & Novel Therapeutics Session Chair: Robert Mealer, MD, PhD | |
| 11:00am-11:30am | Stephen Haggarty, PhD Associate Professor of Neurology, Harvard Medical School; Associate Neuroscientist, Massachusetts General Hospital; Director of the MGH Chemical Neurobiology Laboratory at the Center for Genomic Medicine | |
| 11:30am-12:00pm | Yasmin Hurd, PhD Director of the Addiction Institute, Mount Sinai; Professor, Icahn School of Medicine at Mount Sinai | |
| 12:00pm-12:20pm | BREAK | |
12:20pm-12:50pm | Session: Data & Prediction: The Role of Academia and Industry in Advancing Precision Psychiatry Session Chair: Will Gordon, MD | |
| 12:20pm-12:50pm | Panel Oliver Harrison, MA, MBBS, MPH Founder and Chief Executive Officer, Koa Health; Independent Expert Bank, Wellcome Trust; Roster of Experts- Digital Health, World Health Organization; Scott Kollins, PhD Chief Medical Officer, Holmusk; Strategic Advisor for Digital Health Solutions, Duke Clinical Research Institute Moderator: Will Gordon, MD | |
12:50pm-1:50pm | Session: Genomic Medicine Session Chair: Laura Hercher, MA, MS | |
| 12:50pm-1:20pm | Wendy Chung, MD, PhD Kennedy Family Professor of Pediatrics and Medicine, Columbia University; Precision Medicine Resource Leader, Irving Institute; Medical Director, Columbia Genetic Counseling Graduate Program; Associate Director for Education, Herbert Irving Comprehensive Cancer Center; Chief, Division of Clinical Genetics, Department of Pediatrics | |
| 1:20pm-1:50pm | Jehannine Austin, PhD, MSc Professor in Dept. of Medical Genetics, University of British Columbia; Executive Director, BC Mental Health and Addictions Research Institute | |
| 1:50pm-2:20pm | Moderated Discussion Wendy Chung, MD, PhD and Jehannine Austin, PhD, MSc Moderator: Laura Hercher, MA, MS | |
| 2:20pm-2:30pm | Closing Remarks Jordan W. Smoller, MD, ScD | |
KEYNOTE SPEAKERS
Thomas Insel, MD - Former Director of NIMH; Author of Healing: Our Path from Mental Illness to Mental Health (Penguin Press, 2022)
Kelsey Martin, PhD - Director of the Simons Foundation Autism Research Initiative (SFARI)
SPEAKERS
Jehannine Austin, PhD - Professor in the Department of Medical Genetics, University of British Columbia; Executive Director, BC Mental Health and Addictions Research Institute
Jennifer Barnett, PhD - Chief Executive Officer, Monument Therapeutics; Chief Scientific Officer, Five Lives; Honorary Research Fellow in Dept. of Psychiatry, University of Cambridge
Chad Bousman, PhD - CEO/Founder, Sequence2Script Inc.; Associate Professor, University of Calgary
Wendy Chung, MD, PhD - Kennedy Family Professor of Pediatrics and Medicine, Columbia University; Precision Medicine Resource Leader, Irving Institute; Medical Director, Columbia Genetic Counseling Graduate Program; Associate Director for Education, Herbert Irving Comprehensive Cancer Center; Chief, Division of Clinical Genetics, Department of Pediatrics
Lea Davis, PhD - Associate Professor of Medicine, Biomedical Informatic, Molecular Physiology & Biophysics, and Psychiatry & Behavioral Sciences, Vanderbilt University Medical Center
Laura Germine, PhD - Director of Brain and Cognitive Health Technology, McLean Hospital; Co-director of the Institute for Technology in Psychiatry, McLean Hospital; Assistant Professor, Harvard Medical School; President and Director, The Many Brains Project
Stephen Haggarty, PhD - Associate Professor of Neurology, Harvard Medical School; Associate Neuroscientist, Massachusetts General Hospital; Director of the MGH Chemical Neurobiology Laboratory at the Center for Genomic Medicine
Oliver Harrison, MA, MBBS, MPH - Founder and Chief Executive Officer, Koa Health; Independent Expert Bank, Wellcome Trust; Roster of Experts- Digital Health, World Health Organization
Yasmin Hurd, PhD - Director of the Addiction Institute, Mount Sinai; Professor, Icahn School of Medicine at Mount Sinai
Scott Kollins, PhD - Chief Medical Officer, Holmusk; Strategic Advisor for Digital Health Solutions, Duke Clinical Research Institute
David Olson, PhD - Chief Innovation Officer and Head of the Scientific Advisory Board, Delix Therapeutics; Associate Professor, University of California Davis
Anthony Philippakis, MD, PhD - Chief Data Officer, Broad Institute of MIT and Harvard; Venture Partner, GV
Katherine Scangos, MD, PhD - Medical Director, Neumora ; Co-Director TMS and Neuromodulation Program, University of California San Francisco
Nigam Shah, PhD - Professor of Medicine, Stanford University; Associate Dean and Professor of Medicine and Biomedical Data Science, Stanford University School of Medicine
Morgan Sheng, PhD - Core Institute Member and Co-Director of Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard
Price
COURSE DIRECTORS/PLANNERS
Jordan Smoller, MD, ScD – Director, MGH Center for Precision Psychiatry; Director, MGH Psychiatric and Neurodevelopmental Genetics Unit; Professor of Psychiatry, Harvard Medical School; Professor in Epidemiology, T.H. Chan Harvard School of Public Health
Megan Candito, MA – Marketing and Administrative Coordinator, MGH Center for Precision Psychiatry
Karmel Choi, PhD – Director, Precision Prevention Program at MGH Center for Precision Psychiatry; Clinical Psychologist at MGH; Assistant Professor at Harvard Medical School
Maurizio Fava, MD – Psychiatrist-in-Chief, MGH; Vice Chair, MGH Executive Committee of Research
Roy Perlis, MD - Associate Chief (Research), MGH Department of Psychiatry; Director, MGH Center for Quantitative Health; Director, MGH Center for Experimental Drugs and Diagnostics; Ronald I. Dozoretz, MD Endowed Professor of Psychiatry, Harvard Medical School
Jerrold Rosenbaum, MD – Director, MGH Center for the Neuroscience of Psychedelics; Stanley Cobb Professor of Psychiatry, Harvard Medical School; Co-Founder and Director, Psy Therapeutics, Inc; Co-Founder, Sensorium Therapeutics
Ashley Seiger, MSc – Program Director, MGH Center for Precision Psychiatry
Sabine Wilhelm, PhD – Director, MGH Center for Digital Mental Health; Chief of Psychology, MGH; Director, MGH Center for OCD and Related Disorders; Professor, Harvard Medical School